Moving from one substance to another

A different name does not yet explain the change

“I no longer use the old substance” can describe very different events. Someone has started prescribed treatment, is trying to reduce a particular harm, is looking for another form of relief, or notices that old difficulties are recurring with a new substance. These situations cannot be assessed from a medicine's name, the presence of a prescription, or a promise that “everything is under control now.”

A transition can have an understandable reason: pain, anxiety, insufficient sleep, unpleasant consequences of previous use, cost or unavailable care. Real relief and the ability to work deserve attention. They establish neither a substance use disorder nor an absence of risk. A useful question is what has actually changed in health, freedom to choose and everyday life.

Three different tasks matter here: assessing a treatment change, clarifying the aim of reducing harm, and considering whether a harmful pattern of behaviour remains. They may overlap. But “this is treatment” cannot be decided simply because something comes from a pharmacy, nor “this is a new addiction” simply because it is taken for a long time.

When another substance is part of treatment

For opioid use disorder, prescribed methadone or buprenorphine can be part of treatment. Their use should not automatically be described as exchanging one addiction for another. MedlinePlus explains this distinction and notes that treatment duration varies and may be long. This is not an invitation to choose a medicine yourself or a promise of the same access in every country. MedlinePlus, opioid use disorder treatment.

CDC separately states that detoxification without medication treatment for opioid use disorder is not recommended because of the risks of returning to use, overdose and death. This concerns that approach generally, rather than home detoxification alone. Declining psychosocial support, or its unavailability, should not by itself delay medication treatment for this disorder. These points do not provide a protocol for other substances. CDC, treating opioid use disorder.

For another prescription, a clinician may reconsider treatment because of insufficient benefit, unwanted effects or a changed condition. It helps to understand the purpose of a change, expected benefits, risks and follow-up arrangements before that conversation. A medicine change does not automatically mean a personal deterioration or a guaranteed solution. Continuing treatment need not become a competition to be the first person taking no medicines.

Reducing harm is a specific aim, not permission for any replacement

Someone may say, “My previous use caused too many problems; I want at least to reduce them.” That need makes sense even when the person is unsure about stopping completely. EUDA describes harm reduction as addressing the health, social and economic consequences of substance use, including the needs of people who continue using. It is an area of care and public health, rather than a claim that any other substance is safer. EUDA, harm reduction.

It helps to name a proposed change specifically: fewer dangerous episodes, access to medical care, fewer conflicts, restored sleep or keeping a home. These are aims to discuss, rather than outcomes that can be promised beforehand. A transition may reduce one difficulty, leave another and introduce a new one. “Natural,” “legal” and “odourless” do not replace that assessment.

A replacement made on your own does not become a medical plan through good intentions. A personal account or advertisement cannot establish a universally safe way to switch. Someone who has already changed something can seek help with that history now: they do not have to prove their attempt succeeded first or return to the old substance to make a comparison.

When the substance changes but the old difficulties remain

Consider a hypothetical example. Someone has stopped using one substance, but with another they again spend more than intended, conceal harm they have caused and miss commitments that matter to them. Those continuing difficulties give them something to discuss. This does not prove that everyone who changes substances must “transfer an addiction.”

What matters is concrete behaviour and consequences, rather than the general motive “I need relief” alone. How often do decisions differ from your own intentions? Which responsibilities suffer? Is getting help becoming harder? NIMH describes substance use disorders through patterns of behaviour, difficulties with control and continued use despite harm; diagnosis requires assessment. This article does not turn these questions into a self-test. NIMH, substance use and mental health.

Someone else may receive prescribed treatment, work and gradually repair relationships. A similar outward detail—taking a substance every day—does not make the two accounts equivalent. Doing good work does not, by itself, answer every safety question either. Describing changes already known is more useful than arguing about who is a “real addict” or whose mind is strong enough.

What especially matters with medicines and combinations

Physical adaptation means that changes in taking a substance may be accompanied by withdrawal symptoms. It is not automatically addiction. For antidepressants, the Royal College of Psychiatrists explains this distinction and the need to discuss changes with the prescribing professional. Useful long-term treatment should not be stopped to prove independence. RCPsych, stopping antidepressants.

But the same word “medicine” does not imply the same risks. FDA warns about physical dependence and withdrawal with benzodiazepines, including medical use; abrupt stopping can be dangerous. Combinations with alcohol, opioids and other substances that depress the central nervous system need separate attention. This warning concerns a specific class, rather than an accusation against all prescribed treatment. FDA, benzodiazepines.

During a transition, it matters to tell the professional about both prescribed medicines and other substance use. A replacement may also be a combination if previous use continues. There is no compatibility chart, stopping regimen or recommendation here to add another substance against unpleasant symptoms. Suspected poisoning, unconsciousness or difficulty breathing require immediate local emergency medical help, without waiting for a complete list of substances. NHS, poisoning.

Starting a conversation without a perfect decision

For an initial conversation, describing the question is enough: “I have changed my use and do not know whether it is safer,” “a different treatment has been offered,” or “the old harm keeps recurring.” You need not first accept someone else's explanation of your entire life. Pain, mood, substance use and prescribed treatment can be discussed together; coordinated care considers both concerns rather than requiring one to be ignored. NIMH, joint assessment and care.

If changes are still being considered, they can be discussed with the prescribing professional or an accessible support service. If changes have already happened, shame is not a reason to postpone that conversation. An immediate threat to life calls for urgent medical help; booking a routine appointment does not replace it.

Money, language, transport, waiting lists or a previous unpleasant experience can create practical barriers. A first step can be asking whether a service accepts new people, what a consultation costs, which language it uses and what help is available while waiting. One contact starts a search for care; it does not mean treatment has already been received. SAMHSA, setting up an appointment.

What relatives can do, and what they are not obliged to do

A relative can listen, help record what is already known or offer to accompany the person—with the adult's consent. They may ask about concrete harm without declaring every new treatment another addiction. “Since that change, you have twice missed something important to us” is more precise than a verdict based on a substance's name. Such a conversation does not guarantee agreement.

Participation does not require buying substances, controlling medicines, taking away a phone or turning the home into a place for forced confession. If the person is not ready to discuss the situation, a relative can still state their own boundaries around threats, money and safety. When violence occurs, protecting those harmed matters in its own right; love does not oblige anyone to endure danger.

A child must not become an observer, intermediary or rescuer of an adult. Meaning, warm relationships and environmental changes can offer support, but they do not guarantee an outcome or replace necessary care. A relative may seek their own support and rest too. SAMHSA, caring for yourself while helping someone.

Five optional fields to clarify a transition

This note prepares a conversation; it does not establish a diagnosis or the safety of a replacement. Use only what is already known, and leave any field blank if needed. Do not use a substance, stop a medicine or repeat an experience to fill it in. Notes can wait when danger is immediate.

1. What changed. What was used before and what is used now; name prescribed treatment and other use separately. Mark unknown information as unknown.
2. Why the change happened. What benefit I hope to gain or particular harm I hope to reduce, and what I already feel has changed.
3. What is happening in life. Changes already noticed in sleep, work, health, spending, relationships and following my own intentions—without an experiment to check them.
4. Current care and barriers. Who prescribes treatment, with whom changes can be discussed and what prevents access to help.
5. One next step. Whom I will approach, which question I will ask first and what manageable support I will agree with a relative. This is a contact for discussion, rather than a home switching regimen.

Sources and limits

Sources were checked on 14 October 2026. Specific read passages and verified reuse of the author's own earlier reading were used. Information from the United States, United Kingdom and Europe does not establish local legality, access or an individual prescription. There is no universal substance-switching rule, diagnostic questionnaire or promised outcome here.

• MedlinePlus, Opioid Use Disorder Treatment — updated 27 March 2024; the treatment text and stated limits were read. Source: MedlinePlus, National Library of Medicine. Rights for health-topic summaries were checked separately; they do not license all linked materials or drug monographs.
• CDC, Opioid Use Disorder: Treating — 9 April 2024; verified reuse of the author's own reading on medication care, detoxification without it and access to psychosocial support. Opioid use disorder only, with no regimens transferred.
• EUDA, Harm reduction topics page — the definition and objectives were read; the substantive revision date was not established. EUDA's attribution-based reuse conditions were checked separately, with the exception for third-party material retained.
• NIMH, Finding Help for Co-Occurring Substance Use and Mental Disorders — page reviewed March 2025; behavioural features, joint assessment, care and the text-rights notice were read. Not a self-diagnosis tool.
• Royal College of Psychiatrists, Stopping antidepressants — March 2024; verified reuse of the author's own reading on adaptation versus addiction and discussing prescription changes. Full regimens were not transferred; a general licence for the full text was not established.
• FDA, benzodiazepine class warning — 23 September 2020; verified reuse of the author's own reading on therapeutic benefit and specific risks, rather than the entire adverse-event dataset or an individual regimen.
• NHS, Poisoning — page reviewed 12 June 2025; verified reuse of the author's own reading on urgent care. UK telephone numbers and home procedures were not transferred.
• SAMHSA, How to Set Up an Appointment — 24 April 2023; verified reuse of the author's own reading of the entire displayed official expanded text; direct HTML returned 403. First-contact arrangements, without guarantees of local services.
• SAMHSA, Caring for Yourself — 24 April 2023; verified reuse of the author's own reading of the entire displayed official expanded text; direct opening returned InternalError. Manageable support and boundaries, rather than a family treatment protocol.

Tags

changing substances; addiction; treatment changes; opioid use disorder; medication treatment; harm reduction; physical adaptation; withdrawal symptoms; consequences of use; consent and boundaries; support for relatives; seeking help

About the authors

Andrey Zarinsh is the author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut is a co-author of United Wisdom. Alongside her research, she seeks to test these ideas in practice and observe how principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.